Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Feline vaccine-associated fibrosarcoma: morphologic distinctions.

S S Couto1, S M Griffey, P C Duarte

  • 1Veterinary Medical Teaching Hospital, University of California, School of Veterinary Medicine, Davis, USA. sscouto@ucdavis.edu

Veterinary Pathology
|July 10, 2002
PubMed
Summary

This study characterized feline vaccine-associated fibrosarcomas, finding a correlation between giant cells and higher tumor grade. Peripheral vascularity was greater than central, but proliferation rates were similar.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of the haemoglobin-based oxygen carrier Hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolaemia model.

Veterinary anaesthesia and analgesia·2017
Same author

CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.

Journal of comparative pathology·2015
Same author

Morphologic manifestations of gene-specific molecular alterations ("genetic addictions") in mouse models of disease.

Veterinary pathology·2011
Same author

Human and porcine Taenia solium infections in Mozambique: identifying research priorities.

Animal health research reviews·2011
Same author

The pathologist's slide reveals more than meets the eye: loss of heterozygosity and cancer biology.

Veterinary pathology·2010
Same author

Opportunistic bacterial infections in breeding colonies of the NSG mouse strain.

Veterinary pathology·2010

Area of Science:

  • Veterinary Pathology
  • Oncology
  • Immunology

Background:

  • Feline vaccine-associated sarcomas (FVAS) are aggressive tumors.
  • Understanding their histopathology is crucial for diagnosis and treatment.
  • Previous studies have focused on gross and basic histologic features.

Purpose of the Study:

  • To conduct a detailed histological characterization of primary and recurrent FVAS.
  • To investigate the correlation between tumor grade, specific cellular components, and microvascularity.
  • To analyze the immunophenotype and stromal cell characteristics of FVAS.

Main Methods:

  • Histological examination of 44 primary and 16 recurrent FVAS.
  • Assessment of tumor grade, multinucleated giant cells, lymphocyte populations (T and B cells), and filament content.

Related Experiment Videos

  • Computerized image analysis for microvascularity and proliferation rates in central and peripheral tumor areas.
  • Immunohistochemistry for vimentin and alpha-smooth muscle actin.
  • Main Results:

    • Tumor grading revealed similar distributions for primary and recurrent FVAS (Grade I, II, III).
    • A positive correlation was observed between neoplastic multinucleated giant cells and higher tumor grade (present in 75% of Grade III).
    • Lymphoid aggregates were common (59%), often rich in T lymphocytes (19-87%). Peripheral vascularity exceeded central vascularity, but proliferation rates were comparable.
    • Vimentin was universally expressed; alpha-smooth muscle actin was present in 64% of tumors, associated with tumor cells or capsule formation.

    Conclusions:

    • FVAS exhibit variable histological grades and cellular compositions, with giant cells indicating higher malignancy.
    • Tumor microenvironment includes significant lymphoid infiltration and differential vascularization.
    • Further research into the role of stromal cells and immune components may inform therapeutic strategies for FVAS.